Stone, M.A.; Mayberry, J.F.; Baker, R.B.
April 2003
Gut;Apr2003 Supplement 1, Vol. 52, pA68
Academic Journal
Background: Data from general practice (GP) records in North Tees (Rubin et al, 2000) suggested a higher prevalence of inflammatory bowel disease (IBD) than previous estimates from hospital data. Regular prescribing of 5-aminosalicylic acid (5-ASA) therapy can reduce the risk of colorectal cancer in patients with ulcerative colitis (UC). Aims: To estimate IBD prevalence from GP records in the Trent region of central England and describe the management of patients with this condition, including data regarding 5-ASA prescribing and compliance in UC. Methods: 15 general practices recruited through the Trent Focus Collaborative Research Network provided data on confirmed cases of IBD using a standardised data collection form. Results: 344 patients with IBD were identified from a combined GP list size of 86 801, suggesting a prevalence of 396 per 100 000 (95% confidence interval 356 to 440), much higher than previous estimates from secondary care and similar to results from North Tees. Approximately one third of patients with IBD were considered by GPs to be solely under their care and only 59% of IBD patients had actually been seen as hospital inpatients or outpatients during the previous year. Only 57% of patients with UC (including proctitis) had been prescribed a 5-ASA during the previous 6 months and good compliance with prescribing and taking 5-ASA medication was suggested from the prescribing records of only 42% of these patients (23% all UC patients). Conclusions: Data collection From hospital records may miss some IBD patients. GPs may play an important role in caring for patients with IBD; they should therefore receive good education regarding IBD management, including the importance of 5-ASA therapy in UC.


Related Articles

  • Recent Indications and Methods of Surgery for Inflammatory Bowel Disease. S. Ohki; S. Terashima; K. Sekikawa; S. Takenoshita; M. Gotoh // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p113 

    Inflammatory bowel disease, notably ulcerative colitis (UC) or Crohn disease (CD), is basically benign, but sometimes develops into serious or fatal cancer. While the primary therapies are medical, such as pharmacotherapy and dietetic modification, intractable, serious, and cancerous cases can...

  • Ulcerative colitis. Ghosh, Subrata // BMJ: British Medical Journal (International Edition);04/22/2000, Vol. 320 Issue 7242, p1119 

    Provides information on ulcerative colitis. Clinical features and diagnosis; Etiology; Clinical management; Failure of medical management and its indications for surgery.

  • What's new in inflammatory bowel disease in 2008? Baumgart, Daniel C. // World Journal of Gastroenterology;1/21/2008, Vol. 14 Issue 3, p329 

    Ulcerative colitis and Crohn's disease represent the two major forms of inflammatory bowel disease. In this highlight topic series of articles we cover the latest developments in genetics and epidemiology, intestinal physiology, mucosal immunology, mechanisms of epithelial cell injury and...

  • Chronic Ulcerative Colitis. Levy, Jerome S.; Riherd, Leslie // American Journal of Gastroenterology;Sep1968, Vol. 50 Issue 3, p208 

    Examines the incidence of nonspecific ulcerative colitis in a private general hospital in the U.S. over a three ten-year periods. Method of treatment of ulcerative colitis; Incidence of complications of the disease; Severity of the disorder in Arkansas.

  • Fenotipo e historia natural de la enfermedad inflamatoria intestinal en un centro de referencia en Medell�n-Colombia. Ba�os, Fabi�n Juliao; V�lez, Mario Hern�n Ruiz; Arango, Jos� Fernando Fl�rez; G�mez, Jorge Hernando Donado; Zuluaga, Juan Ignacio Mar�n; Arango, Claudia Monsalve; G�mez, Carlos Andr�s Jim�nez; Zapata, Yineth Agudelo; Velayos, Fernando S. // Revista Colombiana de Gastroenterolog�a;Jul2012, Vol. 25 Issue 3, p240 

    Worldwide the frequencies of inflammatory bowel disease, ulcerative colitis and Crohn�s disease have all increased. In our own environment it has become necessary to establish the epidemiology of these entities and to determine their clinical and endoscopic behavior. Methodology: This is a...

  • Appendectomy and Protection against Ulcerative Colitis. Andersson, Roland E.; Olaison, Gunnar; Tysk, Curt; Ekbom, Anders // New England Journal of Medicine;03/15/2001, Vol. 344 Issue 11, p808 

    Background: A history of appendectomy is rare in patients with ulcerative colitis. This suggests a protective effect of appendectomy or that appendicitis and ulcerative colitis are alternative inflammatory responses. We sought to characterize this inverse relation further. Methods: We studied a...

  • Changes in chemical coding of myenteric neurones in ulcerative colitis. Neunlist, M.; Aubert, P.; Toquet, C.; Oreshkova, T.; Barouk, J.; Lehur, P.A.; Schemann, M.; Galmiche, J.P. // Gut;Jan2003, Vol. 52 Issue 1, p84 

    Background: Morphological and functional changes in the enteric nervous system (ENS) have been reported in inflammatory bowel diseases but it is still uncertain whether neurochemical coding of myenteric neurones is altered in ulcerative colitis (UC). Aims: In this study we investigated...

  • In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Bridger, S.; Lee, J.C.W.; Bjarnason, I.; Lennard Jones, J.E.; Macpherson, A.J. // Gut;Jul2002, Vol. 51 Issue 1, p21 

    Background and aims: Smoking tobacco has opposite effects on the different forms of inflammatory bowel disease (IBD). It predisposes to the development of Crohn's disease (CD) yet is associated with a reduced incidence of ulcerative colitis (UC). We have studied sib pairs discordant for both...

  • Tissue trans-glutaminase antibody in Inflammatory Bowel Disease in Golestan provinc, Northern Iran (2005-08). T., Amiriani; S., Besharat; Sh., Semnani; R., Joshaghani H.; GhR., Roshandel; A., Keshtkar A.; S., Mirkarimi H.; Z., Hashemi-Nasab S.; S., Zendeh-Bad A. // Journal of Gorgan University of Medical Sciences;2011, Vol. 13 Issue 1, p127 

    Background and Objective: Celiac is a hereditary disease presented with chronic inflammation of small intestine. Several studies supposed a relationship between Celiac disease and Inflammatory Bowel Disease (IBD). Tissue trans-glutaminase antibody is one of the best serological markers in Celiac...


Read the Article


Sign out of this library

Other Topics